Immune checkpoint inhibitors in advanced cutaneous melanoma: a systematic review and meta-analysis of efficacy and review of characteristics

CONCLUSION: Our results suggest that ICI-based immunotherapy is associated with enhanced OS, PFS, and RFS (P < 0.001) and will assist clinicians in choosing the optimal approach toward treating metastatic melanoma.PMID:37908134 | DOI:10.1080/14737140.2023.2278509

Source: Expert Review of Anticancer Therapy - November 1, 2023 Category: Cancer & Oncology Authors: Sara Mahdiabadi Sara Momtazmanesh Amirali Karimi Nima Rezaei Source Type: research